Cardiovascular Events with Finerenone in CKD and Diabetes. Reply

N Engl J Med. 2022 Apr 21;386(16):e43. doi: 10.1056/NEJMc2200202.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases* / prevention & control
  • Diabetes Mellitus* / drug therapy
  • Diabetic Nephropathies*
  • Female
  • Humans
  • Male
  • Naphthyridines
  • Renal Insufficiency, Chronic* / complications

Substances

  • Naphthyridines
  • finerenone